Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,652 public trials 850 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A

NCT02406092

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Hôpital Dorban CHU Annaba, Service d'Hématologie Annaba, Algeria
  • EHS CAC Hospital FRANTZ FANON ZABANA BLIDA; Hematology ward Blida, Algeria
  • EHU Oran, Service d'Hématologie et de Thérapie Cellulaire Oran, Algeria
  • Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie Tizi Ouzou, Algeria
View all 13 locations
View Trial Details
Completed

A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China

NCT05896774

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
  • Sir Run Run Shaw Hospital Hangzhou, Zhejiang, China
View Trial Details
Completed

A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL

NCT02268851

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +18 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • St. Francis Hospital and Cancer Center Hartford, Connecticut, United States
  • Eastern Maine Medical Center/ Northern Light Cancer Care Brewer, Maine, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

NCT02924402

Conditions
B-Cell Non-Hodgkins Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +50 more
Locations
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Northside Hospital Atlanta, Georgia, United States
  • The University of Chicago Medicine Chicago, Illinois, United States
View all 23 locations
View Trial Details
Completed

A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma

NCT01871727

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of Alabama at Birmingham, Dermatology at Whitaker Clinic Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Medical Center National Medical Center Duarte, California, United States
  • UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
View all 22 locations
View Trial Details
Completed

Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma

NCT01755975

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Saint Francis/Mount Sinai Regional Cancer Center Hartford, Connecticut, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States
View Trial Details

Related conditions